PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2005 by Therion Biologics Corporation.
Recruitment status was  Active, not recruiting
Information provided by:
Therion Biologics Corporation Identifier:
First received: March 1, 2004
Last updated: July 7, 2005
Last verified: July 2005
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given